Cassling Diagnostic makes management moves
Medical imaging equipment refurbisher Cassling Diagnostic Imaging shifted its management structure this month when it appointed three new executives to posts within its organization and that of its subsidiary, Integrated Equipment Solutions. The Omaha,
Medical imaging equipment refurbisher Cassling Diagnostic Imaging shifted its management structure this month when it appointed three new executives to posts within its organization and that of its subsidiary, Integrated Equipment Solutions. The Omaha, NE, firm named Merl Dunham technical director of its imaging information and integration division. Dunham will manage CDIs integration lab and personnel and will provide technical support and integration coordination. He will report to Marty Huebner, vice president of service. CDI also appointed Randy Wobig to the post of clinical network specialist. Wobig will oversee CDIs networking department. Finally, CDIs subsidiary, Integrated Equipment Solutions, named Dale Ray vice president of sales and marketing. Ray has served as field manager for Philips Medical, vice president of sales and marketing for Fischer Imaging, and has held various management positions with Marconi Medical Systems. He will report to Gary Nie, vice president of integrated services, and will develop the companys worldwide sales force.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
